FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approves Dr. Reddy's Laboratories' supplemental application to add a generic aripiprazole orally disintegrating tablet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Irritability Associated with Autistic Disorder
• Major Depressive Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Aripiprazole Orally Disintegrating (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE ORALLY DISINTEGRATING)